Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of NeuroPace Inc (NASDAQ: NPCE) closed at $10.57 in the last session, up 1.54%% from day before closing price of $10.41. In other words, the price has increased by $1.54% from its previous closing price. On the day, 0.5 million shares were traded. NPCE stock price reached its highest trading level at $10.605 during the session, while it also had its lowest trading level at $9.845.
Ratios:
We take a closer look at NPCE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.70 and its Current Ratio is at 6.63. In the meantime, Its Debt-to-Equity ratio is 3.01 whereas as Long-Term Debt/Eq ratio is at 2.93.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on May 28, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
On January 21, 2025, UBS started tracking the stock assigning a Buy rating and target price of $17.
Wells Fargo Upgraded its Equal Weight to Overweight on March 14, 2024, whereas the target price for the stock was revised from $16 to $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 14 ’25 when ORBIMED ADVISORS LLC sold 168,136 shares for $15.85 per share. The transaction valued at 2,665,333 led to the insider holds 3,238,199 shares of the business.
Morrell Martha sold 78,334 shares of NPCE for $1,074,844 on Feb 21 ’25. The CHIEF MEDICAL OFFICER now owns 81,993 shares after completing the transaction at $13.72 per share. On Feb 20 ’25, another insider, KCK LTD., who serves as the 10% Owner of the company, sold 5,270,845 shares for $9.40 each. As a result, the insider received 49,545,943 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NPCE now has a Market Capitalization of 346680128 and an Enterprise Value of 353570208. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.11 while its Price-to-Book (P/B) ratio in mrq is 14.26. Its current Enterprise Value per Revenue stands at 4.194 whereas that against EBITDA is -18.548.
Stock Price History:
The Beta on a monthly basis for NPCE is 2.04, which has changed by 0.57526076 over the last 52 weeks, in comparison to a change of 0.10163462 over the same period for the S&P500. Over the past 52 weeks, NPCE has reached a high of $18.98, while it has fallen to a 52-week low of $5.45. The 50-Day Moving Average of the stock is -16.66%, while the 200-Day Moving Average is calculated to be -2.26%.
Shares Statistics:
According to the various share statistics, NPCE traded on average about 298.88K shares per day over the past 3-months and 312240 shares per day over the past 10 days. A total of 32.75M shares are outstanding, with a floating share count of 22.82M. Insiders hold about 30.42% of the company’s shares, while institutions hold 61.07% stake in the company. Shares short for NPCE as of 1748563200 were 355768 with a Short Ratio of 1.19, compared to 1745971200 on 393663. Therefore, it implies a Short% of Shares Outstanding of 355768 and a Short% of Float of 1.8399999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
